PR, editorial and Marketing Communications for Agriculture and Animal Health
Now in our 25th year

Portfolio PR writing samples

What's The Story
An animal health company faced negative press after its rabies vaccine was linked to the deaths of some dogs. Distributed to trade and local media outlets, this press release proactively addressed the issue and provided assurances that it was an isolated problem.

Vaccine maker lends full support to N.J. rabies probe

MENDOTA HEIGHTS, Minn. — A Minnesota animal health company said today it was investigating reports that its rabies vaccine caused adverse side effects in a few dogs immunized at New Jersey rabies vaccination clinics.

“We identified a few serials of rabies vaccine where the incidence of reactions was considered to be higher than normal, but we found no problem with the vaccine’s potency or effectiveness, nor was there any need to have those dogs re-vaccinated,” said Dr. Jerry Quinlan, a veterinarian and Manager of Professional Services for Solvay Animal Health, Inc.

“This appears to be an isolated problem limited to a few serials of the vaccine to the Jersey area, and most veterinarians and dog owners in the state have not experienced any difficulty with the vaccine.”

Quinlan emphasized that all rabies vaccines need to pass government testing standards prior to release. “We nevertheless share the concerns New Jersey veterinarians or pet owners may have resulting from these recent reports, and we’re taking measures to regain the market’s confidence,” he said.

In a recent letter, Solvay advised New Jersey veterinarians of the reports and said it was monitoring the situation with both the state Veterinary Medical Association and Department of Health. Furthermore, Solvay has offered to replace any product in question.

“In light of the isolated reports of reactions, we felt that offering to replace product was the prudent and responsible thing to do. There is no need to have pets re-vaccinated,” Dr. Quinlan said.

The veterinarian explained that all vaccines used in veterinary and human medicine have the potential to cause reactions such as swelling or fever within 24 hours of administration, but the incidence is generally low.

“We were concerned when we heard the reports because this particular rabies vaccine has a very strong safety record,” Quinlan explained. Over the past two years, for example, Solvay Animal Health averaged less than 5 reported reactions per 100,000 doses (0.0045%) of the vaccine administered in the United States and Canada, he reported. Moreover, occurrence of reactions to the vaccine in New Jersey — as reported in a recent communication from the New Jersey Coordinator of Veterinary Product Health — has been less then 1 percent.

“Of the serials in question, 0.08 percent was the highest reaction rate we saw — and that is still considered very low,” Quinlan said.

Solvay Animal Health scientists are working to identify what caused the reported reactions at the state-sponsored community rabies vaccination clinics. The company said it was conducting numerous tests and would report its findings to the U.S. Department of Agriculture, which regulates vaccines, the N.J. Department of Health and the N.J. Veterinary Medical Association.

“Community-sponsored rabies vaccination clinics have made a tremendous contribution to the war against rabies, and we support the continuation of these programs,” Quinlan said.

“It's important to note, however, that pets brought to free vaccination clinics cannot always be thoroughly examined. In most cases, it is not advisable to vaccinate an animal that is already under stress from a health problem since reactions are more likely to occur. Pet owners need to keep that in mind and understand that these community vaccination clinics are no substitute for routine veterinary care.”

The N.J. Department of Health has suspended use of the vaccine, sold under the name Rabvac, in state-sponsored veterinary clinics pending results of Solvay’s investigation. In a recent letter to its members, the state veterinary medical association said the health department’s actions were “solely precautionary in nature, and not intended to recommend against the use of Rabvac.”

Quinlan added that Rabvac was still considered safe to use. “The probability of veterinarians and pet owners in New Jersey seeing an abnormal rate of reaction is still very low,” Quinlan added, “but we wanted to take a pro-active stance and make them aware of these isolated occurrences.”

Pet owners who suspect any abnormal reactions to rabies vaccination should contact their veterinarian.